JP2017031144A5 - - Google Patents

Download PDF

Info

Publication number
JP2017031144A5
JP2017031144A5 JP2016146924A JP2016146924A JP2017031144A5 JP 2017031144 A5 JP2017031144 A5 JP 2017031144A5 JP 2016146924 A JP2016146924 A JP 2016146924A JP 2016146924 A JP2016146924 A JP 2016146924A JP 2017031144 A5 JP2017031144 A5 JP 2017031144A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
psychogenic
composition according
factor
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016146924A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017031144A (ja
JP6914626B2 (ja
Filing date
Publication date
Priority claimed from JP2015148778A external-priority patent/JP2016056166A/ja
Application filed filed Critical
Publication of JP2017031144A publication Critical patent/JP2017031144A/ja
Publication of JP2017031144A5 publication Critical patent/JP2017031144A5/ja
Application granted granted Critical
Publication of JP6914626B2 publication Critical patent/JP6914626B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016146924A 2015-07-28 2016-07-27 経口用医薬組成物 Active JP6914626B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015148778A JP2016056166A (ja) 2015-07-28 2015-07-28 経口用医薬組成物
JP2015148778 2015-07-28

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021017086A Division JP7123205B2 (ja) 2015-07-28 2021-02-05 経口用医薬組成物

Publications (3)

Publication Number Publication Date
JP2017031144A JP2017031144A (ja) 2017-02-09
JP2017031144A5 true JP2017031144A5 (enExample) 2019-08-15
JP6914626B2 JP6914626B2 (ja) 2021-08-04

Family

ID=55757540

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015148778A Pending JP2016056166A (ja) 2015-07-28 2015-07-28 経口用医薬組成物
JP2016146924A Active JP6914626B2 (ja) 2015-07-28 2016-07-27 経口用医薬組成物
JP2021017086A Active JP7123205B2 (ja) 2015-07-28 2021-02-05 経口用医薬組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2015148778A Pending JP2016056166A (ja) 2015-07-28 2015-07-28 経口用医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021017086A Active JP7123205B2 (ja) 2015-07-28 2021-02-05 経口用医薬組成物

Country Status (1)

Country Link
JP (3) JP2016056166A (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018090549A (ja) * 2016-12-07 2018-06-14 第一三共ヘルスケア株式会社 ロキソプロフェンとジヒドロコデインリン酸塩を含有する固形製剤
JP7557963B2 (ja) * 2019-05-30 2024-09-30 第一三共ヘルスケア株式会社 月経困難症の予防及び/又は治療のための組合せ医薬

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011168580A (ja) * 2010-01-19 2011-09-01 Daiichi Sankyo Healthcare Co Ltd 医薬組成物

Similar Documents

Publication Publication Date Title
JP2015525757A5 (enExample)
JP2019513639A5 (enExample)
MY191357A (en) Sustained-release dosage forms of ruxolitinib
JP2015143836A5 (enExample)
JP2016501828A5 (enExample)
JP2015057451A5 (enExample)
JP2014218522A5 (enExample)
JP2017505809A5 (enExample)
JP2017537912A5 (enExample)
HRP20211868T1 (hr) Derivati aminopiridina i njihova uporaba kao selektivnih inhibitora za alk-2
JP2018524307A5 (enExample)
JP2017061576A5 (enExample)
JP2017031144A5 (enExample)
JP2013005790A5 (enExample)
CN106794183A (zh) 含有细胞周期蛋白抑制剂的药物制剂及其制备方法
CL2016000182A1 (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
JP2012525422A5 (enExample)
JP2015521598A5 (enExample)
JP2019014666A5 (enExample)
MX385513B (es) Composiciones farmaceuticas que comprenden safinamida.
JP2018150270A5 (enExample)
RU2013144966A (ru) Композиция, содержащая диаминоксидазу, для применения для лечения или предотвращения фибромиалгии или синдрома хронической усталости
JP2017052778A5 (enExample)
JP2016540798A5 (enExample)
JP2011032288A5 (enExample)